Fusion proteins as immunization treatments of alzheimer's disease

摘要

The present invention is related to fusion proteins (A beta -Hsp) (III) and their use in the treatment or prophylaxis of disorders associated with an accumulation of beta -amyloid, specifically in patients with Alzheimer's disease. Said fusion proteins (III) are derived from the condensation of beta -amyloid protein or fr agments thereof (A beta ) (I) with a heat shock protein (Hsp) (II ) according to the following pathway: (Formula).